BRF2 and non-small cell lung carcinoma: Our study showed no statistically significant prognostic role for FGFR1 or BRF2 gene copy number in surgically resected NSCLC patients when using our predefined FISH scoring criteria, although a trend for improved survival for FGFR1+ or BRF2+ patients could be observed in the whole population.